Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MASSACHUSETTS WILL REQUIRE "NO SUBSTITUTION" STATEMENT IN WRITING

Executive Summary

MASSACHUSETTS WILL REQUIRE "NO SUBSTITUTION" STATEMENT IN WRITING as of Nov. 1, in order for a physician to preclude generic substitution. Under the Massachusetts state law entitled "Increasing the Availability of Generic Drugs," a one-line substitution form will replace a two-line form permitting a choice between "dispense as written" or "interchange." Massachusetts prescription pads, after Nov. 1, will have to carry the statement: "Interchange is mandated unless the practitioner writes the words 'no substitution' in this space." The new state law makes Massachusetts the 26th state with a one-line prescription pad format. Other states with legislation mandating the format are Florida, Hawaii, Kentucky and Vermont. The majority of the 26 states with one-line forms, including California, Michigan, Ohio and the District of Columbia, have laws permitting the format. The Massachusetts legislation was enacted on Dec. 16, 1985. It is part of Chapter 582 of the state Acts of 1985. According to the Massachusetts Department of Public Health, the two lobbying groups pushing for the change were Mass PIRG (Public Interest Research Group) and the Legislative Council of Older Americans.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS010894

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel